-
Systems Analysis of Single-Cell Heterogeneity Underlying Glioma Drug Resistance
Study
phs003501
-
Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor
Study
phs003413
-
Structure of the Mucosal and Stool Microbiome in Lynch Syndrome
Study
phs002343
-
Correlative Studies for Protocol #14-C-0059: T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Patients with GD2+ Solid Tumors, a Collaboration with CIMAC-CIDC
Study
phs003455
-
Transcriptomic Profiling of Peripheral Immune Cells in a Trial of Ruxolitinib with Nivolumab for Anti-PD1 Non-Responsive cHL
Study
phs003601
-
Identification of High-Risk PHF19 Expressing Cells in Myeloma Single-Cell Multiomics
Study
phs003220
-
ILyAD (Indolent Lymphoma And vitamin D)
Study
phs003503
-
Comprehensive Genomic Characterization of Translocation Renal Cell Carcinoma
Study
phs003008
-
Aberrant Activation of Wound Healing Programs within the Metastatic Niche Facilitates Lung Colonization by Osteosarcoma Cells
Study
phs003569
-
Childhood Cancer Data Initiative (CCDI): Single-Cell Atlas of NF1 Nerve Sheath Tumors
Study
phs003519
-
Basal-to-Inflammatory Transition Contributes to Basal Cell Carcinoma Therapy Resistance via Crosstalk with a Pro-Inflammatory Stromal Niche
Study
phs003437
-
EWS-WT1 Fusion Isoforms Establish Oncogenic Programs and Therapeutic Vulnerabilities in Desmoplastic Small Round Cell Tumors
Study
phs003682
-
Genetic Analysis of Skin Cells
Study
phs003282
-
Multi-Omic Profiling of Glioma Patient Tumors and Patient-Derived Model Systems
Study
phs003286
-
Evolving Cell States and Oncogenic Drivers during the Progression of IDH-Mutant Gliomas
Study
phs003697
-
Chromothripsis in Small Cell Lung Carcinoma Associated with Carcinoid Transformation
Study
phs003676
-
The Somatic Mutational Landscape of Thyroid Cancer in Patients with Germline PTEN Mutations
Study
phs003640
-
Phase 2 Study of Nivolumab and Entinostat in Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma
Study
phs003615
-
Clinical Outcomes and ctDNA Correlates for CAPOX BETR: A phase II trial of Capecitabine, Oxaliplatin, Bevacizumab, Trastuzumab in Previously Untreated Advanced HER2+ Gastroesophageal Adenocarcinoma
Study
phs003706
-
Genomic Analysis of Diffuse Large B Cell Lymphoma
Study
phs003634
-
Single Cell RNA-Seq Reveals Malignant and Stromal Programs Associated with Metastasis in Head and Neck Cancer
Study
phs001474
-
Gene Variants in Pheochromocytoma and Paraganglioma
Study
phs002405
-
Comprehensive Genomic Data Deposition for Pancreatic Cancer Precision Medicine Studies: Clinical Trials NCT02451982 and NCT02648282
Study
phs003600
-
Pre-Existing Skin-Resident CD8 and γδ T Cell Circuits Mediate Immune Response in Merkel Cell Carcinoma and Predict Immunotherapy Efficacy
Study
phs003629
-
Single-Cell Analysis of the Multiple Myeloma Microenvironment after Gamma-Secretase Inhibition and CAR T-Cell Therapy
Study
phs003741